Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
J Immunol. 2011 Aug 1;187(3):1403-10. doi: 10.4049/jimmunol.1002352. Epub 2011 Jun 29.
Chemerin, a ligand for the G-protein coupled receptor chemokine-like receptor 1, requires C-terminal proteolytic processing to unleash its chemoattractant activity. Proteolytically processed chemerin selectively attracts specific subsets of immunoregulatory APCs, including chemokine-like receptor 1-positive immature plasmacytoid dendritic cells (pDC). Chemerin is predicted to belong to the structural cathelicidin/cystatin family of proteins composed of antibacterial polypeptide cathelicidins and inhibitors of cysteine proteinases (cystatins). We therefore hypothesized that chemerin may interact directly with cysteine proteases, and that it might also function as an antibacterial agent. In this article, we show that chemerin does not inhibit human cysteine proteases, but rather is a new substrate for cathepsin (cat) K and L. cat K- and L-cleaved chemerin triggered robust migration of human blood-derived pDC ex vivo. Furthermore, cat K- and L-truncated chemerin also displayed antibacterial activity against Enterobacteriaceae. Cathepsins may therefore contribute to host defense by activating chemerin to directly inhibit bacterial growth and to recruit pDC to sites of infection.
趋化素是一种 G 蛋白偶联受体趋化素样受体 1 的配体,需要 C 端蛋白水解处理才能释放其趋化活性。蛋白水解处理的趋化素选择性地吸引特定的免疫调节 APC 亚群,包括趋化素样受体 1 阳性未成熟浆细胞样树突状细胞 (pDC)。趋化素预计属于结构抗菌肽/半胱氨酸蛋白酶抑制剂家族的蛋白质,由抗菌多肽抗菌肽和半胱氨酸蛋白酶抑制剂 (cystatins) 组成。因此,我们假设趋化素可能直接与半胱氨酸蛋白酶相互作用,并且它也可能作为一种抗菌剂发挥作用。在本文中,我们表明趋化素不会抑制人类半胱氨酸蛋白酶,而是组织蛋白酶 (cat) K 和 L 的新底物。cat K 和 L 切割的趋化素可触发人体血液衍生的 pDC 的体外迁移。此外,cat K 和 L 截断的趋化素对肠杆菌科也具有抗菌活性。因此,组织蛋白酶可能通过激活趋化素直接抑制细菌生长并募集 pDC 到感染部位来参与宿主防御。